Raptakos Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2019.
2019 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Raptakos Pharma Private Limited

Raptakos Pharma Private Limited, a active private limited company, was established on 19 October 2019 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U15490MH2019PTC331918. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Vijay Harishchandra Tagwale (Director), Suhrud Shantilal Jhaveri (Director). Past directors included Vijay Harishchandra Tagwale, Shashikant Mahadeo Kane. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-715, Floor -7Th, B Wing, Plaza Panchashil, Nyaymurti Sitaram Patkar Marg, Grant Roa, D, Mumbai, Maharashtra, 400007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U15490MH2019PTC331918

  • Registration Number

    331918

  • Incorporation Date

    19 October 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** -54.68%
  • Ebitda **** -54.68%
  • Net Worth -43.60%
  • Total Assets -24.46%
Company report

Raptakos Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Raptakos Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Raptakos Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Vijay Harishchandra Tagwale Director 03 Nov 2020 Current
Suhrud Shantilal Jhaveri Director 19 Oct 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2021 Past
Pramod Abcsdd Director 03 Nov 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Raptakos Pharma.

Raptakos Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 54.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 43.6%.

Raptakos Pharma revenue growth over time
Raptakos Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -24.46%
*******
*******
*******
*******
Profit or Loss
*******
 -54.68%
*******
*******
*******
*******
Net Worth
*******
 -43.60%
*******
*******
*******
*******
EBITDA
*******
 -54.68%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Raptakos Pharma?

In 2021, Raptakos Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Raptakos Pharma?

Unlock and access historical data on people associated with Raptakos Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Raptakos Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raptakos Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Raptakos Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Raptakos Pharma Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Raptakos Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    Progress on Vijay Harishchandra Tagwale was appointed as a Director was appointed as a Director on 03 Nov 2020 & has been associated with this company since 5 years 3 months . was documented.

  • Director Appointment

    Suhrud Shantilal Jhaveri was appointed as a Director was appointed as a Director on 19 Oct 2019 & has been associated with this company since 6 years 4 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Raptakos Pharma Private Limited was registered on 19 Oct 2019 with Roc Mumbai & aged 6 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Raptakos Pharma Private Limited?

The CIN of Raptakos Pharma Private Limited is U15490MH2019PTC331918.

Where is Raptakos Pharma Private Limited headquartered?

Raptakos Pharma Private Limited is headquartered at B-715, Floor -7Th, B Wing, Plaza Panchashil, Nyaymurti Sitaram Patkar Marg, Grant Roa, D, Mumbai, Maharashtra, 400007.

When was Raptakos Pharma Private Limited incorporated?

Raptakos Pharma Private Limited was incorporated on 19 October 2019.

Who are the current directors of Raptakos Pharma Private Limited?

The current directors of Raptakos Pharma Private Limited are

What is the primary industry of Raptakos Pharma Private Limited?

The primary industry of Raptakos Pharma Private Limited is Pharma.

Is Raptakos Pharma Private Limited a listed company?

Raptakos Pharma Private Limited is unlisted.

What is the capital structure of Raptakos Pharma Private Limited?

The authorized capital of Raptakos Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available